CureVac NV (5CV) — Cash Flow Reinvestment Rate

Latest as of September 2025: 0.02x

CureVac NV (5CV) has a Cash Flow Reinvestment Rate of 0.02x as of September 2025, reinvesting €644.00K (capex €322.00K plus investments €-322.00K) from operating cash flow of €29.86 Million. See cash generation quality of CureVac NV to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.02x
(Capex + Investments) / Operating CF

Total Reinvested

€644.00K
Capex + Investments

Operating Cash Flow

€29.86 Million
EUR

Capital Expenditures

€322.00K
EUR

CureVac NV Cash Flow Reinvestment Rate (2020–2024)

Historical reinvestment intensity for CureVac NV across 2 annual periods. For the full cash flow conversion analysis, see 5CV cash generation efficiency.

Annual Cash Flow Reinvestment Rate for CureVac NV (2020–2024)

Year-by-year capital reinvestment analysis for CureVac NV. See 5CV FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2024 0.36x €36.89 Million €101.85 Million €18.44 Million ▲ +404.7%
2020 0.07x €37.49 Million €522.40 Million €36.33 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow